Insider: Tanimoto Sarina CHIEF MEDICAL OFFICER - ARS Pharmaceuticals, Inc.
| Company Holdings |
| Direct | Indirect Ownership | Total | |
| Shares | 1,247,447 | 1,247,447 | |
| Value | $ | $10,116,795.17 | $10,116,795.17 |
Trans. Date |
Trans. Type |
Shares |
Ownership Type |
Issue Type |
Price |
Trans. Value |
Total Shares Owned |
|---|---|---|---|---|---|---|---|
| 08/20/2025 | DDS | 37,656 | Indirect | COM | $14.09 | $530,625.76 | 1,247,447 |
| 08/19/2025 | DDS | 12,344 | Indirect | COM | $14.03 | $173,129.54 | 1,285,103 |
| 12/17/2024 | DDS | 50,000 | Indirect | COM | $11.67 | $583,575.00 | 1,297,447 |
| 12/17/2024 | DDS | 50,000 | Indirect | COM | $11.67 | $583,525.00 | 1,098,499 |
| 12/10/2024 | DDS | 50,000 | Indirect | COM | $13.17 | $658,265.00 | 1,246,494 |
| 12/10/2024 | DDS | 50,000 | Indirect | COM | $13.16 | $658,155.00 | 1,148,499 |
| 11/19/2024 | DDS | 50,000 | Indirect | COM | $13.95 | $697,450.00 | 1,198,499 |
| 11/19/2024 | DDS | 50,000 | Indirect | COM | $13.95 | $697,510.00 | 1,347,447 |
| 11/12/2024 | DDS | 45,045 | Indirect | COM | $16.76 | $754,904.65 | 1,301,449 |
| 11/12/2024 | DDS | 4,955 | Indirect | COM | $17.64 | $87,421.07 | 1,296,494 |
| 11/12/2024 | DDS | 4,876 | Indirect | COM | $17.64 | $86,020.44 | 1,248,499 |
| 11/12/2024 | DDS | 45,124 | Indirect | COM | $16.76 | $756,296.29 | 1,253,375 |
| 10/15/2024 | DDS | 1,450 | Indirect | COM | $15.25 | $22,118.16 | 1,397,447 |
| 10/15/2024 | DDS | 48,550 | Indirect | COM | $14.86 | $721,656.91 | 1,398,897 |
| 10/15/2024 | DDS | 50,000 | Indirect | COM | $14.88 | $743,820.00 | 1,298,499 |
| 10/08/2024 | DDS | 50,000 | Indirect | COM | $13.83 | $691,385.00 | 1,346,494 |
| 10/08/2024 | DDS | 50,000 | Indirect | COM | $13.83 | $691,390.00 | 1,348,499 |
| 09/17/2024 | DDS | 50,000 | Indirect | COM | $12.93 | $646,525.00 | 1,447,447 |
| 09/17/2024 | DDS | 50,000 | Indirect | COM | $12.93 | $646,680.00 | 1,398,499 |
| 09/10/2024 | DDS | 50,000 | Indirect | COM | $11.50 | $574,865.00 | 1,396,494 |
| 09/10/2024 | DDS | 50,000 | Indirect | COM | $11.50 | $574,910.00 | 1,448,499 |
| 08/20/2024 | DDS | 11,756 | Indirect | COM | $15.61 | $183,545.25 | 1,499,747 |
| 08/20/2024 | DDS | 35,944 | Indirect | COM | $14.76 | $530,407.64 | 1,511,503 |
| 08/20/2024 | DDS | 2,300 | Indirect | COM | $16.26 | $37,395.47 | 1,497,447 |
| 08/20/2024 | DDS | 36,216 | Indirect | COM | $14.76 | $534,461.24 | 1,512,283 |
| 1 2 3 Next Last You are at page 1 of 3 pages |
|
Transaction Type Key First letter: A = Acquired, D = Disposed Second letter: A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust |
 |
Send to Excel |
© 2000 - 2026 Zacks Investment Research